BioHarvest Sciences (TSE:BHSC) has released an update.
BioHarvest Sciences has successfully completed the first tranche of its private placement, raising USD $4.33 million by issuing over 600,000 share units, alongside the early conversion of debt notes which resulted in over 93% of its convertible notes being exercised. The capital will bolster the company’s CDMO business, enhance its manufacturing capabilities, and address general corporate needs. BioHarvest’s unique botanical synthesis technology continues to position it as a pioneer in the development of plant-based molecules for health and wellness products.
For further insights into TSE:BHSC stock, check out TipRanks’ Stock Analysis page.
